XML 29 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Equity - USD ($)
shares in Thousands, $ in Millions
Total
Total XPO Stockholders’ Equity
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss
Non-controlling Interests
Series A Preferred Stock
Preferred Stock
Balance at beginning of period (in shares) at Dec. 31, 2019     92,342         72
Balance at beginning of period at Dec. 31, 2019 $ 2,896 $ 2,743 $ 0 $ 2,061 $ 786 $ (145) $ 153 $ 41
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 117 110     110   7  
Other comprehensive income (loss) (7) (13)       (13) 6  
Exercise and vesting of stock compensation awards (in shares)     1,411          
Tax withholdings related to vesting of stock compensation awards (47) (47)   (47)        
Purchase of noncontrolling interests (21) (1)   (1)     (20)  
Conversion of preferred stock to common stock (in shares)     (10,014)         71
Conversion of preferred stock to common stock       (40)       $ 40
Preferred stock conversion (22) (22)     (22)      
Retirement of common stock (in shares)     (1,715)          
Retirement of common stock (114) (114)   (114)        
Dividend declared (8) (2)     (2)   (6)  
Stock compensation expense 52 52   52        
Adoption of new accounting standard and other 3 3   7 (4)      
Balance at end of period (in shares) at Dec. 31, 2020     102,052         1
Balance at end of period at Dec. 31, 2020 2,849 2,709 $ 0 1,998 868 (158) 140 $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 341 336     336   5  
Other comprehensive income (loss) (54) (52)       (52) (2)  
Spin-off (2,274) (2,234)   (1,199) (1,161) 126 (40)  
Exercise and vesting of stock compensation awards (in shares)     392          
Exercise and vesting of stock compensation awards 2 2   2        
Tax withholdings related to vesting of stock compensation awards (28) (28)   (28)        
Issuance of common stock (in shares)     2,875          
Issuance of common stock 384 384   384        
Purchase of noncontrolling interests (134) (34)   (34)     (100)  
Conversion of preferred stock to common stock (in shares)     (145)         1
Conversion of preferred stock to common stock       (1)       $ 1
Dividend declared (3) 0         (3)  
Exercise of warrants (in shares)     9,215          
Stock compensation expense 52 52   52        
Other (in shares)     58          
Other 3 3   3        
Balance at end of period (in shares) at Dec. 31, 2021     114,737         0
Balance at end of period at Dec. 31, 2021 1,138 1,138 $ 0 1,179 43 (84) 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 666 666     666      
Other comprehensive income (loss) (140) (140)       (140)    
Spin-off (711) (711)     (713) 2    
Exercise and vesting of stock compensation awards (in shares)     698          
Exercise and vesting of stock compensation awards 0 0            
Tax withholdings related to vesting of stock compensation awards (23) (23)   (23)        
Stock compensation expense 77 77   77        
Other 5 5   5        
Balance at end of period (in shares) at Dec. 31, 2022     115,435         0
Balance at end of period at Dec. 31, 2022 $ 1,012 $ 1,012 $ 0 $ 1,238 $ (4) $ (222) $ 0 $ 0